Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-10

  Kai, Wei ^a   Xiaojun, Xu ^b   Ximing, Pu ^a   Zhenqing, Hou ^a   Qiqing, Zhang ^a,c  

^a XIAMEN UNIVERSITY   (China)

^b Zhejiang Fishery Technical Extention Center   (China)

^c INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

Author keywords

Apoptosis; BEL 7402; Cell cycle; Magnetic nanoparticles; Mitochondrial dependent pathway

Indexed keywords

BEL-7402; CASPASE-3 ACTIVATION; CELL CYCLE; CYTOCHROME C; CYTOSOLS; CYTOTOXIC EFFECTS; DOSE-DEPENDENT MANNER; FLOW CYTOMETRY ANALYSIS; HUMAN HEPATOMAS; MAGNETIC NANOPARTICLES; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL-DEPENDENT PATHWAY; OVER-EXPRESSION;

CELL DEATH; CELL MEMBRANES; CYTOTOXICITY; FLOW CYTOMETRY; MITOCHONDRIA; NANOPARTICLES; OLEIC ACID;

NANOMAGNETICS;

EID: 84856077893     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-480     Document Type: Article

References (58)

1. M G: Travels to the nanoworld: miniature machinery in nature and technology. New York: Plenum Trade; 1999.
2. Kim D, El-Shall H, Dennis D, Morey T: Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf B Biointerfaces 2005, 40:83-91.
3. Perkel JM: Nanoscience is Out of the Bottle. The scientist 2003, 17:20-23.
4. Boutry S, Laurent S, Elst LV, Muller RN: Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol Imaging 2006, 1:15-22.
5. Mornet S, Vasseur S, Grasset F, Veverka P, Goglio G, Demourgues A, Portier J, Pollert E, Duguet E: Magnetic nanoparticle design for medical applications. Progress in Solid State Chemistry 2006, 34:237-247.
6. Dobson J: magnetic nanoparticles for drug delivery. Drug Development Research 2006, 67:55-60.
7. Mykhaylyk O, Zelphati O, Hammerschmid E, Anton M, Rosenecker J, Plank C: Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol 2009, 487:111-146.
8. Clement JH, Schwalbe M, Buske N, Wagner K, Schnabelrauch M, Gornert P, Kliche KO, Pachmann K, Weitschies W, Hoffken K: Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells. J Cancer Res Clin Oncol 2006, 132:287-292.
9. Gazeau F, Levy M, Wilhelm C: Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine (Lond) 2008, 3:831-844.
10. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA: Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010, 30:15-35.
11. Wang YX, Hussain SM, Krestin GP: Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
12. Bonnemain B: Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review. J Drug Target 1998, 6:167-174.
13. Shen YF, Tang J, Nie ZH, Wang YD, Ren Y, Zuo L: Preparation and application of magnetic Fe3O4 nanoparticles for wastewater purification. Separation and Purification Technology 2009, 68:312-319.
14. Zhang D, Wei S, Kaila C, Su X, Wu J, Karki AB, Young DP, Guo Z: Carbonstabilized iron nanoparticles for environmental remediation. Nanoscale 2010, 2:917-919.
15. Scheenen TW, Vergeldt FJ, Heemskerk AM, Van As H: Intact plant magnetic resonance imaging to study dynamics in long-distance sap flow and flow-conducting surface area. Plant Physiol 2007, 144:1157-1165.
16. Gonzalez-Melendi P, Fernandez-Pacheco R, Coronado MJ, Corredor E, Testillano PS, Risueno MC, Marquina C, Ibarra MR, Rubiales D, Perez-de-Luque A: Nanoparticles as smart treatment-delivery systems in plants: assessment of different techniques of microscopy for their visualization in plant tissues. Ann Bot 2008, 101:187-195.
17. Corredor E, Testillano PS, Coronado MJ, Gonzalez-Melendi P, Fernandez- Pacheco R, Marquina C, Ibarra MR, de la Fuente JM, Rubiales D, Perez-de- Luque A, Risueno MC: Nanoparticle penetration and transport in living pumpkin plants: in situ subcellular identification. BMC Plant Biol 2009, 9:45.
18. Cifuentes Z, Custardoy L, de la Fuente JM, Marquina C, Ibarra MR, Rubiales D, Perez-de-Luque A: Absorption and translocation to the aerial part of magnetic carbon-coated nanoparticles through the root of different crop plants. J Nanobiotechnology 2010, 8:26.
19. Moore MN: Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 2006, 32:967-976.
20. Service RF: Nanotoxicology. Nanotechnology grows up. Science 2004, 304:1732-1734.
21. Zhang S, Chen X, Gu C, Zhang Y, Xu J, Bian Z, Yang D, Gu N: The Effect of Iron Oxide Magnetic Nanoparticles on Smooth Muscle Cells. Nanoscale Res Lett 2009, 4:70-77.
22. Ying E, Hwang HM: In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 2010, 408:4475-4481.
23. Wu X, Tan Y, Mao H, Zhang M: Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine 2010, 5:385-399.
24. Soto K, Garza KM, Murr LE: Cytotoxic effects of aggregated nanomaterials. Acta Biomater 2007, 3:351-358.
25. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ: In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
26. Pisanic TR, Blackwell JD, Shubayev VI, Finones RR, Jin S: Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572-2581.
27. Auffan M, Decome L, Rose J, Orsiere T, De Meo M, Briois V, Chaneac C, Olivi L, Berge-Lefranc JL, Botta A, Wiesner MR, Bottero JY: In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ Sci Technol 2006, 40:4367-4373.
28. Barua S, Rege K: Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small 2009, 5:370-376.
29. Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P: Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 1996, 13:245-255.
30. Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM: Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res 2004, 316:315-323.
31. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V: Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 2008, 5:316-327.
32. Tomitaka A, Hirukawa A, Yamada T, Morishita S, Takemura Y: Biocompatibility of various ferrite nanoparticles evaluated by in vitro cytotoxicity assays using HeLa cells. Journal of Magnetism and Magnetic Materials 2009, 321:1482-1484.
33. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI: Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 2007, 115:403-409.
34. Soenen SJ, De Cuyper M: Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging 2009, 4:207-219.
35. Gupta AK, Curtis AS: Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004, 25:3029-3040.
36. Wang J, Sun P, Bao Y, Liu J, An L: Cytotoxicity of single-walled carbon nanotubes on PC12 cells. Toxicol in Vitro 2011, 25:242-250.
37. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S: TEM Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
38. Ishikawa K, Ishii H, Saito T: DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 2006, 25:406-411.
39. Merdan T, Kopecek J, Kissel T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002, 54:715-758.
40. Wang ZY, Zhao Y, Ren L, Jin LH, Sun LP, Yin P, Zhang YF, Zhang QQ: Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy. Nanotechnology 2008, 19.
41. Cho SG, Choi EJ: Apoptotic signaling pathways: caspases and stressactivated protein kinases. J Biochem Mol Biol 2002, 35:24-27.
42. Ho PK, Hawkins CJ: Mammalian initiator apoptotic caspases. FEBS J 2005, 272:5436-5453.
43. Chen X, Deng C, Tang S, Zhang M: Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol Pharm Bull 2007, 30:128-132.
44. Woldemariam GA, Mandal SS: Iron(III)-salen damages DNA and induces apoptosis in human cell via mitochondrial pathway. Journal of Inorganic Biochemistry 2008, 102:740-747.
45. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G: Mitochondria and programmed cell death: back to the future. FEBS Lett 1996, 396:7-13.
46. Wang X, Xia Y, Liu L, Liu M, Gu N, Guang H, Zhang F: Comparison of MTT assay, flow cytometry, and RT-PCR in the evaluation of cytotoxicity of five prosthodontic materials. J Biomed Mater Res B Appl Biomater 2010, 95:357-364.
47. Antonsson B, Montessuit S, Sanchez B, Martinou JC: Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 2001, 276:11615-11623.
48. Yethon JA, Epand RF, Leber B, Epand RM, Andrews DW: Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem 2003, 278:48935-48941.
49. Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DW, Piette J: Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 2001, 20:4070-4084.
50. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C: Vital functions for lethal caspases. Oncogene 2005, 24:5137-5148.
51. Suzuki N, Urano J, Tamanoi F: Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells. Proc Natl Acad Sci USA 1998, 95:15356-15361.
52. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
53. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT: Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278:294-298.
54. Sonnemann J, Gange J, Pilz S, Stotzer C, Ohlinger R, Belau A, Lorenz G, Beck JF: Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients. BMC Cancer 2006, 6:183.
55. Soenen SJ, Himmelreich U, Nuytten N, Pisanic TR, Ferrari A, De Cuyper M: Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010, 6:2136-2145.
56. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T: Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 2004, 36:976-984.
57. Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H: Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007, 244:514-523.
58. Huang DM, Hsiao JK, Chen YC, Chien LY, Yao M, Chen YK, Ko BS, Hsu SC, Tai LA, Cheng HY, Wang SW, Yang CS, Chen YC: The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009, 30:3645-3651.